DNA/RNA 추출 키트 시장 : 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the DNA/RNA extraction kit market size is expected to grow from USD 1.77 billion in 2025 to USD 1.89 billion in 2026 and is forecast to reach USD 2.68 billion by 2031 at 7.23% CAGR over 2026-2031.

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope Of The Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Adoption of Liquid Biopsy in Oncology Diagnostics
  • 4.2.2 Technological Advancements in Automated High-Throughput Extraction Platforms
  • 4.2.3 Growing Investments in Molecular Diagnostic R&D
  • 4.2.4 Expansion of Precision Medicine Programs and Companion Diagnostics
  • 4.2.5 Increasing Use of Residential Point-of-Care Genomic Testing Kits
  • 4.2.6 Wastewater Epidemiology Demand for Viral RNA Surveillance
• 4.3 Market Restraints
  • 4.3.1 High Capital And Reagent Costs of Automated Extraction Systems
  • 4.3.2 Limited Skilled Workforce in Low-Resource Settings
  • 4.3.3 Regulatory Scrutiny Over Microplastic Waste from Single-Use Plastics in Kits
  • 4.3.4 Supply Chain Vulnerabilities for Silica And Magnetic Bead Raw Materials
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Bargaining Power Of Buyers
  • 4.7.2 Bargaining Power Of Suppliers
  • 4.7.3 Threat Of New Entrants
  • 4.7.4 Threat Of Substitute Products
  • 4.7.5 Intensity Of Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Product
  • 5.1.1 Cell Free DNA
  • 5.1.2 Sequence Specific DNA
  • 5.1.3 Sequence Specific RNA
  • 5.1.4 Total RNA
  • 5.1.5 Other Products
• 5.2 By Sample Type
  • 5.2.1 Blood & Plasma
  • 5.2.2 Tissue & FFPE
  • 5.2.3 Saliva & Buccal Swab
  • 5.2.4 Wastewater & Environmental Samples
  • 5.2.5 Other Samples
• 5.3 By Technology
  • 5.3.1 Silica Column-Based
  • 5.3.2 Magnetic Bead-Based
  • 5.3.3 Anion-Exchange Resin
  • 5.3.4 Reagent-Based (Phenol-Chloroform, Trizol, Etc.)
  • 5.3.5 Automated Cartridge & Lab-On-Chip
• 5.4 By End User
  • 5.4.1 Diagnostic Centers & Clinical Labs
  • 5.4.2 Hospitals
  • 5.4.3 Research & Academic Institutes
  • 5.4.4 Biotechnology & Pharmaceutical Companies
  • 5.4.5 CROs & Others
• 5.5 Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest Of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest Of Asia-Pacific
  • 5.5.4 Middle East And Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest Of Middle East And Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest Of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles {(Includes Global Level Overview, Market Level Overview, Core Segments, Financials as Available, Strategic Information, Market Rank/Share for Key Companies, Products & Services, and Recent Developments)}
  • 6.3.1 Agilent Technologies
  • 6.3.2 Bio-Rad Laboratories Inc.
  • 6.3.3 bioMerieux SA
  • 6.3.4 Danaher Corp. (Beckman Coulter)
  • 6.3.5 DiaSorin S.p.A.
  • 6.3.6 F. Hoffmann-La Roche AG
  • 6.3.7 GenScript Biotech Corp.
  • 6.3.8 Illumina Inc.
  • 6.3.9 Merck KGaA (MilliporeSigma)
  • 6.3.10 New England Biolabs
  • 6.3.11 Omega Bio-Tek Inc.
  • 6.3.12 PerkinElmer Inc.
  • 6.3.13 Promega Corp.
  • 6.3.14 Qiagen N.V.
  • 6.3.15 Takara Bio Inc.
  • 6.3.16 Thermo Fisher Scientific Inc.
  • 6.3.17 Tecan Group AG
  • 6.3.18 Zymo Research Corp.

7 Market Opportunities & Future Outlook

• 7.1 White-Space & Unmet-Need Assessment